# Contact Reviews NAD: NAD+ Research Digest

> Contact Reviews NAD, an independent editorial digest of the NAD+ research literature. Editorial and correction inquiries only — not a clinic, not a vendor, no medical advice.

Editorial questions, citation corrections, and source suggestions are welcome. Medical questions belong with a qualified professional.

## Editorial inquiries

Reviews NAD is an editorial project covering the NAD+ research literature. Use the form below for the things we can actually help with: a citation that looks wrong, a recent study we should read, a clarity issue in how we summarized a trial, or a correction. We take sourcing seriously — if we have mischaracterized what a study measured, tell us and we will fix it.

We cannot answer personal medical questions, recommend products, or advise on doses. Those are matters for a qualified healthcare professional who knows your situation. Nothing on this site is medical advice, and we do not sell or supply anything.

## What to expect

This is a small editorial operation, not a help desk or a clinical service. We do not provide consultations, prescriptions, or product fulfillment, and we have no clinical staff behind the page. Correction and source-suggestion messages are the most useful kind, and the ones we prioritize. For the evidence base itself, the [full reference list](/references) and the [recent NAD+ research](/research) are the best starting points.

---

A billboard reading of the NAD+ record — the precursor trials that reliably raise blood NAD+ set in large type, the rapidly-cleared IV claims and the still-preliminary human endpoints qualified in the line beneath, the FDA injectable recall and the NMN-supplement dispute flagged in plain sight; no clinic behind the broadcast and nothing here infused, dosed, prescribed, or sold.